The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial

The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial

Abstract Background Mild cognitive impairment (MCI) is an intermediate phase between normal aging and dementia. Since a majority of amnestic MCI (aMCI) cases progress to Alzheimer’s disease (AD), it is considered the prodromal stage of AD and, therefore, a treatment target for the prevention of furt...

Full description

Bibliographic Details
Main Authors: Hee-Yeon Shin, Jeong-Hwa Kim, Geon-Ho Jahng, Woo-Sang Jung, Seong-Uk Park, Chang-Nam Ko, Jung-Mi Park
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Trials
Subjects:
Mild cognitive impairment (MCI)
Kami Guibi-tang
Herbal medicine
Seoul Neuropsychological Screening Battery (SNSB)
Magnetic Resonance Imaging (MRI)
Brain metabolite
Online Access:http://link.springer.com/article/10.1186/s13063-019-3567-1

Internet

http://link.springer.com/article/10.1186/s13063-019-3567-1

Similar Items